<DOC>
	<DOCNO>NCT00614666</DOCNO>
	<brief_summary>The purpose study determine nikkomycin Z safe administer different dose level 14 day . The study also determine blood level urinary excretion nikkomycin Z relation dose administer . Patients mild form Valley Fever pneumonia eligible participate allocate receive treatment nikkomycin Z ( various dos ) placebo . A secondary goal study evaluate effectiveness dose response nikkomycin Z exploratory analysis .</brief_summary>
	<brief_title>Safety PK Nikkomycin Z Coccidioides Pneumonia Treatment</brief_title>
	<detailed_description>Every year 50,000 new U.S. case coccidioidomycosis ( Valley Fever ) . The majority illnesses occur result endemic exposure Arizona California . The benefit antifungal therapy uncomplicated disease currently establish . Current therapy serious complicate form coccidioidomycosis partially effective unable eradicate fungus sit infection , commonly result breakthrough infection and/or relapse . Nikkomycin Z effective mouse model result improve microbiological response fluconazole . The goal study include : 1 ) Evaluating safety tolerance nikkomycin Z follow administration multiple dos ( 50 mg Q 12 h 750 mg Q 8 h ) two week 2 ) Evaluating pharmacokinetics nikkomycin Z single multiple dos relationship dose . The study include patient uncomplicated Coccidioides pneumonia ( mild illness ) allow exploratory analysis efficacy dose response base biomarkers .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Coccidioidomycosis</mesh_term>
	<mesh_term>Coccidiosis</mesh_term>
	<mesh_term>Nikkomycin</mesh_term>
	<criteria>Age &gt; = 18 year &lt; = 50 year Male Female ( female , must negative pregnancy test agree use acceptable contraception method ) Able understand study give write informed consent Have respiratory illness least one following : Cough , chest pain dyspnea tachypnea , sputum production , fever/chills/night sweat Have new suspect new pulmonary infiltrate Chest Xray Have positive coccidioidal serology EIA immunodiffusion Patients age 18 year 50 year Patients history confirm coccidioidal infection Laboratory diagnosis another etiology inclusiondefining illness Inability comprehend study provide inform consent History current evidence major organ disease Concomitant use prednisone corticosteroid permit Concomitant immunosuppressive therapy permit Concomitant antibacterial therapy permit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>coccidioidomycosis</keyword>
	<keyword>Valley Fever</keyword>
	<keyword>nikkomycin Z</keyword>
</DOC>